0001074828
false
0001074828
2022-04-05
2022-04-05
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April
5, 2022
KNOW LABS, INC.
(Exact name of registrant as specified in its charter)
| Nevada |
000-30262 |
90-0273142 |
| (State of other jurisdiction |
(Commission |
(IRS Employer |
| of incorporation) |
File Number) |
Identification No.) |
500
Union Street, Suite 810
Seattle,
Washington 98101
(Address of principal executive office)
(206)
903-1351
(Registrant’s telephone number, including area
code)
(Former name, former address and former fiscal year,
if changed since last report)
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a -12)
☐ Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
☐ Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Securities registered pursuant to Section 12(b) of the
Act: None
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company. ☐
If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 8.01 Other Events.
On April 5, 2022, Know Labs, Inc. a Nevada
corporation (the “Company”), announced that it has been granted the following two patents:
U.S. Patent No. 11,284,819: Analyte Database Established Using Analyte
Data From Non-Invasive Analyte Sensors
U.S. Patent No. 11,284,820: Analyte Database Established Using Analyte
Data From A Non-Invasive Analyte Sensor
The patents were issued by the United States Patent and Trademark Office.
The two patents protect the ability to create and utilize any database built with data captured through non-invasive sensors. This widens
the technological gap between Know Labs and others pursuing non-invasive diagnostics, while opening up a much broader range of protection
for non-invasive analyte data collection and management, beyond human health.
A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated
herein by reference.
Item 9.01 Financial Statements and Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Registrant: KNOW LABS, INC.
By: /s/ Ronald P. Erickson
Ronald P. Erickson
Chairman of the Board
April 5, 2022
- 2 -